A detailed history of Fmr LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Fmr LLC holds 3,956 shares of STAA stock, worth $127,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,956
Previous 3,629 9.01%
Holding current value
$127,304
Previous $138,000 36.23%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$38.07 - $52.25 $12,448 - $17,085
327 Added 9.01%
3,956 $188,000
Q1 2024

May 13, 2024

BUY
$27.67 - $39.61 $43,303 - $61,989
1,565 Added 75.82%
3,629 $138,000
Q4 2023

Feb 13, 2024

SELL
$30.6 - $43.78 $52,326 - $74,863
-1,710 Reduced 45.31%
2,064 $64,000
Q3 2023

Nov 13, 2023

BUY
$39.39 - $58.12 $80,079 - $118,157
2,033 Added 116.77%
3,774 $151,000
Q2 2023

Aug 11, 2023

SELL
$50.45 - $72.82 $34,558 - $49,881
-685 Reduced 28.24%
1,741 $91,000
Q1 2023

May 11, 2023

SELL
$51.25 - $79.34 $1.59 Million - $2.47 Million
-31,080 Reduced 92.76%
2,426 $155,000
Q4 2022

Feb 13, 2023

SELL
$46.82 - $76.2 $121,638 - $197,967
-2,598 Reduced 7.2%
33,506 $1.63 Million
Q3 2022

Nov 10, 2022

SELL
$70.55 - $111.58 $355,572 - $562,363
-5,040 Reduced 12.25%
36,104 $2.55 Million
Q2 2022

Aug 12, 2022

BUY
$50.24 - $80.48 $696,175 - $1.12 Million
13,857 Added 50.78%
41,144 $2.92 Million
Q1 2022

May 13, 2022

BUY
$57.98 - $93.5 $1.57 Million - $2.53 Million
27,082 Added 13210.73%
27,287 $2.18 Million
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $15,403 - $22,363
-175 Reduced 46.05%
205 $19,000
Q3 2021

Nov 15, 2021

SELL
$122.75 - $162.68 $2,086 - $2,765
-17 Reduced 4.28%
380 $48,000
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $41,986 - $61,519
397 New
397 $60,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.55B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.